The U.S. Government Accountability Office (GAO) is an independent agency that works for Congress. The GAO watches over Congress, and investigates how the federal government spends taxpayers dollars. The Comptroller General of the United States is the leader of the GAO, and is appointed to a 15-year term by the U.S. President. The GAO wants to support Congress, while at the same time doing right by the citizens of the United States. They audit, investigate, perform analyses, issue legal decisions and report anything that the government is doing. This is one of their reports.
In 2004, an ad hoc committee was charged with preparing this third report examining the most senior S&T appointments to federal government positions and updating the accompanying list of the most urgent S&T presidential appointments. Sufficient changes have occurred since the National Academies 2000 report on presidential appointmentsâ€"including the 2001 terrorist attacks, the anthrax deaths, the reorganization of homeland-security activities in the federal government, new developments in S&T, and concerns about the politicization of S&T decision making and adviceâ€"to warrant this new edition. In contrast with previous reports on the subject, this one covers not only presidential appointments to top S&T leadership positions but also the appointment of scientists, engineers, and health professionals to serve on federal advisory committees that focus on science-based policy or on the review of research proposals. The committee recognizes that other areas of federal responsibility are as important as S&T, but S&T appointments are the only ones within its purview.
The new Obama administration and the 110th Congress elected in November 2008 will face immediate challenges. Events will not permit a leisurely leadership transition. The prompt appointment of a Presidential science adviser and the nomination of top officials in the new administration with the knowledge and experience to address complex problems will be essential. The concerns of the nation regarding jobs and economic growth, health care, national security, energy, and the environment demand informed action. Each of these concerns-from national security, economic development, health care, and the environment, to education, energy, and natural resources-is touched in essential ways by the nation's science and technology enterprise. This is the fourth in a series of books from the National Academies on the presidential appointment process, each delivered during a presidential election year with the goal of providing recommendations to the President-elect about appointing his senior science and technology leadership and pursuing sustained improvements in the appointments process.
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.